T1	Participants 145 202	donor allogeneic hematopoietic cell transplantation (HCT)
T2	Participants 276 490	study conducted from 2000 to 2003 of palifermin, a recombinant human keratinocyte growth factor, dosed from 240 microg/kg to 720 microg/kg, in 100 allogeneic hematopoietic stem cell transplantation (HCT) recipients
